| Execution period | 48 months |
|---|
BSE filing, NSE: INDIGOPNTS. Summary written from the filing by ALFA Finder's alert engine.
Indigo Paints Ltd: key numbers
- Share price
- ₹1,012.90
- Market cap
- ₹4,835 Cr
- Revenue (annual)
- ₹1,405 Cr
- Net profit (annual)
- ₹145.1 Cr
- P/E (TTM)
- 30.1×Sector 42.1×
- Promoter holding
- 53.81%-0.07% QoQ
- FII holding
- 5.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indigo Paints Ltd
All →Indigo Paints Other Announcement
Indigo Paints Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Indigo Paints Board Meeting Date
Indigo Paints will hold a board meeting on October 30, 2026, to consider and approve standalone and consolidated financial results for the period ended September 30, 2026.
Indigo Paints Other Announcement
Indigo Paints filed the mandatory Regulation 74(5) compliance certificate for the quarter ended September 30, 2026, issued by its registrar.
Indigo Paints Annual General Meeting
Indigo Paints held its 26th Annual General Meeting on September 12, 2026. Shareholders adopted financial results, approved the final dividend, and ratified director appointments.
Indigo Paints Earnings Call Transcript: Key Takeaways
Indigo Paints reported strong double-digit growth in Q1 FY27, outperforming the paint sector with expanded EBITDA and PAT margins. Management highlighted successful operational leverage and distribution network depth.
Indigo Paints Business Update
Indigo Paints Limited submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26 in compliance with SEBI LODR regulations.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.